New FDA alert on CCSVI procedures

[Marco]

The FDA has issued a new alert on CCSVI.

“Because there is no reliable evidence from controlled clinical trials that this procedure is effective in treating MS, FDA encourages rigorously-conducted, properly-targeted research to evaluate the relationship between CCSVI and MS,” said William Maisel, M.D., M.P.H., chief scientist and deputy director for science in the FDA’s Center for Devices and Radiological Health.

The FDA alert can be found here:
http://www.fda.gov/NewsEvents/Newsro.../ucm303538.htm